文献速递临床试验与 GCP

阴部神经脉冲射频联合奇神经节阻滞治疗阴部神经痛的疗效:一项随机临床试验

Efficacy of ganglion impar block combined with pudendal nerve pulsed radiofrequency for pudendal neuralgia management-a randomized clinical trial.
PubMed 文献 · Trials · 2024-05-13

本研究为随机对照临床试验方案,拟纳入84例药物治疗或物理治疗无效的阴部神经痛患者,随机分为单用阴部神经脉冲射频组与阴部神经脉冲射频联合奇神经节阻滞组,主要结局为视觉模拟量表疼痛强度变化,次要结局包括焦虑自评量表评分、抑郁自评量表评分、口服镇痛药使用、健康调查简表36项评分及不良事件发生情况。

要点

  • 拟纳入84例药物或物理治疗无效的阴部神经痛患者,随机分为单药治疗组与联合治疗组。
  • 主要结局为视觉模拟量表疼痛强度变化,次要结局包括焦虑抑郁评分、口服镇痛药使用及生活质量。
  • 安全性通过监测不良事件并在两组间比较评估。

核心结论

  • 该研究方案描述了一项随机对照临床试验,旨在确定单用阴部神经脉冲射频与联合奇神经节阻滞治疗阴部神经痛患者的疗效和安全性。
  • 研究结果将为该联合治疗的潜在获益提供有价值的信息,并有助于为阴部神经痛患者开发更有效和更安全的治疗方法。

研究设计与样本

  • 随机对照临床试验方案,计划纳入84例药物治疗或物理治疗无效的阴部神经痛患者。
  • 患者将被随机分配至单药治疗组(阴部神经脉冲射频)或联合治疗组(阴部神经脉冲射频联合奇神经节阻滞)。
  • 主要结局为视觉模拟量表测量的疼痛强度变化。
  • 次要结局包括焦虑自评量表评分、抑郁自评量表评分、口服镇痛药使用、健康调查简表36项评分及不良事件发生情况。
  • 研究结果将采用意向性治疗分析和符合方案分析,并按初始病因、年龄和基线疼痛强度进行亚组分析。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Pudendal neuralgia is a chronic and debilitating condition. Its prevalence ranges from 5 to 26%. Currently, therapeutic approaches to treat pudendal neuralgia include patient education, medication management, psychological and physical therapy, and procedural interventions, such as nerve block, trigger point injections, and surgery. Drug therapy has a limited effect on pain relief. A pudendal nerve block may cause a significant decrease in pain scores for a short time; however, its efficacy significantly decreases over time. In contrast, pudendal nerve pulsed radiofrequency can provide pain relief for 3 months, and ganglion impar block has been widely used for treating chronic perineal pain and chronic coccygodynia. This study aimed to determine the efficacy and safety of monotherapy (pudendal nerve pulsed radiofrequency) and combination therapy (pudendal nerve pulsed radiofrequency plus ganglion impar block) in patients with pudendal neuralgia. METHODS: This randomized, controlled clinical trial will include 84 patients with pudendal neuralgia who failed to respond to drug or physical therapy. Patients will be randomly assigned into one of the two groups: mono or combined treatment groups. The primary outcome will be a change in pain intensity measured using the visual analog scale. The secondary outcomes will include a Self-Rating Anxiety Scale score, Self-Rating Depression Scale score, the use of oral analgesics, the Medical Outcomes Study Health Survey Short Form-36 Item score, and the occurrence of adverse effects. The study results will be analyzed using intention-to-treat and per-protocol analyses. Primary and secondary outcomes will be evaluated between the mono and combined treatment groups. Subgroup analyses will be conducted based on the initial ailment, age, and baseline pain intensity. The safety of the treatment will be assessed by monitoring adverse events, which will be compared between the two groups. DISCUSSION: This study protocol describes a randomized, controlled clinical trial to determine the efficacy and safety of mono and combination therapies in patients with pudendal neuralgia. The study results will provide valuable information on the potential benefits of this combination therapy and contribute to the development of more effective and safer treatments for patients with pudendal neuralgia. TRIAL REGISTRATION: Chinese Clinical Trial Registry (ChiCTR2200061800).

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Ran J, Lu F, Xu L, et al. Efficacy of ganglion impar block combined with pudendal nerve pulsed radiofrequency for pudendal neuralgia management-a randomized clinical trial. Trials. 2024. PMID: 38741220. doi:10.1186/s13063-024-08152-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。